News | March 11, 2024
Briefs: Zydus Lifesciences and Rainbow Children's Medicare
Zydus Lifesciences receives EIR report from USFDA for API Ahmedabad facility
Zydus Lifesciences receives EIR report from USFDA for API Ahmedabad facility
The validations confirm the completion of the applications and commence the scientific review process
Earlier, he worked with Cadila Pharmaceuticals Limited, Cipla, Alkem Laboratories, and Wockhardt, and started his career with Novartis
The objective of GCMC is well aligned to WHO’s call to action and India’s National Biotechnology Development Strategy
Survodutide has potential to become best-in-class treatment for metabolic dysfunction-associated steatohepatitis
Both the Ministries signed MoU for anaemia control among adolescent girls using Ayurveda interventions
Orchid is the first company from India, ever to have invented a product which has received a New Drug Approval (NDA) from USFDA
Exblifeb demonstrates remarkable efficacy in treating complicated Urinary Tract Infections (cUTI), pneumonia
Tatva Chintan Pharma Chem has reported total income of Rs. 85.41 crores during the period ended December 31, 2023
Approval based on a separate phase III trial among Chinese patients reinforcing mepolizumab’s efficacy and safety data
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
